Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| SHPH | Shuttle Pharmaceuticals | $3.91 | $2.28 | 139.88% | 85.9M | $2.6M | $1.26$25.25 |
| TWG | Top Wealth Group | $7.15 | $3.67 | 105.46% | 37.8M | $5.1M | $3.25$28.11 |
| CRVS | Corvus Pharmaceuticals | $15.36 | $7.31 | 90.81% | 26.7M | $601M | $2.54$16.60 |
| RAPT | Rapt Therapeutics | $57.50 | $22.40 | 63.80% | 14.5M | $973M | $5.67$57.61 |
| POLA | Polar Power | $2.62 | $0.94 | 55.79% | 18.5M | $4.5M | $1.31$5.75 |
| ICON | Icon Energy | $2.99 | $1.05 | 54.12% | 21.8M | - | $1.94$440.00 |
| BTTC | Black Titan | $2.52 | $0.82 | 48.24% | 60.3M | $15M | $1.51$39.00 |
| ACRS | Aclaris Therapeutics | $3.53 | $0.91 | 34.73% | 2.9M | $284M | $1.05$3.57 |
| NUAI | New Era Energy & Digital | $5.71 | $1.38 | 31.87% | 7.6M | $231M | $0.32$7.59 |
| IBRX | ImmunityBio | $7.08 | $1.56 | 28.26% | 1.9M | $5.4B | $1.83$7.36 |
Related Articles
Featured Article
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
Keith Noonan|Aug 12, 2025
Mind Medicine stock hasn't beaten the market over the last five years, but what comes next?
1 Reason to Buy MindMed (MNMD)
Eric Volkman|Aug 7, 2025
The U.S. public and the nation's politicians seem to be coming around to the idea of reforming psychedelic drug laws. Looser restrictions on research would help this company.
This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher
David Jagielski, CPA|Apr 25, 2024
For investors with a high level of risk tolerance, Mind Medicine could be an intriguing investment option.
Advertisement
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
George Budwell, PhD|Dec 27, 2023
Wall Street is uber-bullish on these two Ark Invest holdings.
Could United Microelectronics Become the Next TSMC?
Leo Sun|Jan 15, 2023
Investors shouldn't ignore Taiwan's second-largest contract chipmaker.
Wall Street Says This Stock Can Deliver a 543% Return. Should You Listen?
Cory Renauer|Sep 15, 2022
Find out why investment bank analysts think this stock is positioned for a six-fold gain.
This Meme Stock Just Did a Huge Reverse Stock Split
David Jagielski, CPA|Sep 8, 2022
Is Mind Medicine a buy?
After Its Reverse Stock Split, Is Mind Medicine a Buy?
Alex Carchidi|Sep 5, 2022
If you can stomach the risks, the reverse split doesn't change much of anything.
3 Reasons Why Mind Medicine Might Be the Next Monster Meme Stock
Alex Carchidi|Sep 2, 2022
It already has many of the ingredients for memehood.
3 Growth Stocks That Could Soar 51% to 385%, According to Wall Street
Cory Renauer|Aug 22, 2022
Expectations for these stocks are still sky high.
